Letrozole API

Letrozole API
Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter of Letrozole API, delivering high-quality oncology APIs to pharmaceutical companies across 40+ international markets. Letrozole is a non-steroidal aromatase inhibitor widely used in the treatment of hormone-positive breast cancer, making us a preferred Letrozole bulk API supplier from India.
Globally, Holiness Pharmaceutical is recognized among reputable Letrozole API manufacturers, offering high assay purity, strict impurity control, excellent stability, and consistent batch-to-batch quality suitable for regulated oncology formulations. Our expertise in complex anticancer molecules positions us as a dependable Pharmaceutical API exporter.
Our oncology API manufacturing facilities operate in strict compliance with international regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, robust impurity profiling, and full pharmacopeial compliance for Letrozole API.
We export Letrozole API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing life-saving anticancer therapies. Holiness Pharmaceutical is widely trusted as a bulk Letrozole API supplier.
Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, offering GMP-compliant manufacturing systems, consistent product quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.
Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, oncology synthesis, commercial-scale manufacturing, quality assurance, and worldwide API distribution.
Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.
Send Inquiry
More products from Anti-Cancer/Oncology
| Product Name | CAS Number | Grade | Form | Actions |
|---|---|---|---|---|
Docetaxel API | 114977-28-5 | BP/USP | API Powder | View Product |
Azacitidine API | 320-67-2 | BP/USP | API Powder | View Product |
Carboplatin API | 41575-94-4 | BP/EP/USP | API Powder | View Product |
Carboplatin API | 41575-94-4 | BP/EP/USP | API Powder | View Product |
Cytarabine API | 147-94-4 | IP/BP/USP | API Powder | View Product |
Decitabine API | 2353-33-5 | BP/USP | API Powder | View Product |
Gemcitabine HCl API | 122111-03-9 | IP/BP/USP | API Powder | View Product |
Lenalidomide Analog API | 191732-72-6 | IH | API Powder | View Product |
Letrozole API | 112809-51-5 | IP/USP | API Powder | View Product |
Olaparib API | 763113-22-0 | IP/BP/USP | API Powder | View Product |